Creighton University is looking for participants in the following studies:
- Changes in Quadriceps Function Following Local or Distant Interventions in Individuals with Patelloremoral Pain
- Comparison of Two Medications to Prevent Spine Fractures
- Diabetes Kids Study
- Diabetes Study on the Effectiveness of an Oral Anti-diabetic Medication in Type 2 Diabetes Patients with Increased Cardiovascular Risk and Insufficient Diabetes Control
- Effect of an Osteoporosis Medicine on Healing Hip Fractures
- Family Studies in Hereditary Cancer
- Hatha Yoga as a Way to Quit Smoking
- Insulin 500
- Meningitis Vaccine Study for 10-12 Year Olds
- PARADIGM-HF: A Comparison of LCZ696 to Enalapril in Patients with Chronic Heart Failure
- PEGASUS-TIMI 54: An Investigational Drug Added to Standard Treatment for Patients Who Have Had a Heart Attack in the Last 3 Years
- Pulmonary Arterial Hypertension (PAH): Newly Diagnosed Patients
- Pulmonary Fibrosis
- Stop Smoking Study
- Study of Escitalopram (Lexapro) in Children 7 to 11 Years of Age with Major Depressive Disorder
- Study of Reduced Bone Quality as a Cause of Fractures
- Study to Evaluate the Safety and Effectiveness of an MMRV (Measles, Mumps, Rubella, Varicella) Vaccine Made with an Alternative Manufacturing Process
- Testing Blood Cells in Relation to Asthma
- A Treatment Study for Women with Osteoporosis with Teriparatide or Denosumab
- Type 2 Diabetes Study
- Young Women's Bone Health Study
Confidential Research Hotline (402-280-3200)
Research Personnel are expected to report any known or suspected noncompliant conduct related to research or sponsored program activities conducted and/or approved through Creighton University. The confidential Research Compliance Hotline (402-280-3200) is available for any individual who wishes to remain anonymous and/or has found other available reporting mechanisms to be ineffective. Research Personnel may also address their research compliance-related questions or concerns to Kathy Taggart, Associate Vice President for Research and Compliance, at 402-280-2360.
